Understanding Cardiac Amyloidosis: Role of Cardiac Magnetic Resonance Imaging
暂无分享,去创建一个
[1] M. Benson,et al. Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis , 2010, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[2] Matthew W. Martinez,et al. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. , 2010, JACC. Cardiovascular imaging.
[3] N. Paul,et al. Quantitative assessment of myocardial T2 relaxation times in cardiac amyloidosis , 2009, Journal of magnetic resonance imaging : JMRI.
[4] R. Falk,et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis , 2005, American journal of hematology.
[5] P. Poole‐Wilson,et al. Cardiovascular Magnetic Resonance in Cardiac Amyloidosis , 2005, Circulation.
[6] Jeroen J. Bax,et al. Assessment of diastolic function by cardiovascular magnetic resonance. , 2002, American heart journal.
[7] C. Masters,et al. Amyloid Fibril Protein Nomenclature - 2002 , 2002, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[8] J. Seward,et al. Doppler characterization of left ventricular diastolic function in cardiac amyloidosis. , 1989, Journal of the American College of Cardiology.
[9] It Istituto Superiore di Sanit,et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from th 10th International Symposium on Amyloid an Amyloidosis, Tours, France, 18-22 April 2004 , 2005 .